Context Capital Management LLC bought a new position in LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) during the first quarter, Holdings Channel.com reports. The fund bought 225,000 shares of the company's stock, valued at approximately $2,246,000.
Other large investors have also made changes to their positions in the company. Starboard Value LP acquired a new position in LAVA Medtech Acquisition during the 4th quarter valued at $474,000. Fifth Lane Capital LP acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $986,000. Radcliffe Capital Management L.P. acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $1,000,000. Oaktree Capital Management LP acquired a new stake in shares of LAVA Medtech Acquisition during the 4th quarter worth about $2,500,000. Finally, Toronto Dominion Bank acquired a new stake in shares of LAVA Medtech Acquisition during the 1st quarter worth about $2,994,000. Institutional investors and hedge funds own 31.65% of the company's stock.
Get LAVA Medtech Acquisition alerts:LAVA Medtech Acquisition Trading Up 0.1 %
Shares of LAVA Medtech Acquisition stock opened at $10.06 on Thursday. The company has a 50-day simple moving average of $10.00 and a 200 day simple moving average of $9.97. LAVA Medtech Acquisition Corp. has a 12-month low of $9.83 and a 12-month high of $10.06.
LAVA Medtech Acquisition Company Profile
(Get Rating)LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.
Read More
- Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
Want to see what other hedge funds are holding LVAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating).
Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.